艾比欧义（杭州）生物科技有限公司获“Pre-A轮”融资，金额数千万人民币
Sou Hu Cai Jing·2026-01-17 02:12
Group 1 - The core point of the article is that Aibio (Hangzhou) Biotechnology Co., Ltd. has recently completed a Pre-A round financing, raising several tens of millions of RMB, with investment from the AI Seed Fund under Pudong Venture Capital Group [1] - Aibio was established in 2024 and is located in Hangzhou, focusing on research and experimental development [1] - The registered capital of Aibio is 1.206666 million RMB, and it completed its Pre-A round financing in 2026 [1] Group 2 - Aibio has made investments in 2 external companies and holds 15 trademark registrations and 6 patents [1] - The company has 3 administrative licenses [1] - The shareholders of Aibio include Liu Dapeng and several consulting partnerships [1]